American Marconi Wireless News - Moderna to Present at Upcoming Conferences in March 2025

Thukukile Zuma Resigns from ANC Johannesburg Leadership Amid Disciplinary Dispute
Russia Orders 100,000 Kometa Modules to Counter Ukrainian Electronic Warfare
CM Mohan Yadav Meets Bohra Spiritual Leader to Discuss Simhastha 2028 and Development
Mahayuti-backed Rajesh Patil Elected Chairman of Gokul Dairy Amidst Political Deadlock
Eli Crane Defeats Jonathan Nez in Tight Arizona Congressional Race
David Walliams Identified as Celebrity in Sexual Misconduct Allegations After Legal Bid
Sherilyn Smith Encourages Women to Embrace Scars as Symbols of Resilience
Korea's Severe Asthma Patients Blocked from Biologics by Restrictive Reimbursement Rules
Belgium Signs Contract for 20 Rheinmetall Skyranger Air Defence Systems
Shanghai Science and Technology Museum Signs Pacts With London and Ottawa Institutions at CIIE

NYSE - LSE

RIO	-2.19%	84.54	$
CMSC	-1.89%	20.08	$
CMSD	-1.99%	20.08	$
BTI	1.2%	60.82	$
RELX	-0.28%	39.91	$
BCE	0.69%	21.64	$
BCC	-3.05%	70.42	$
NGG	-0.77%	83.62	$
GSK	-0.61%	51.23	$
RYCEF	2.23%	17.9	$
AZN	-1.41%	186.76	$
RBGPF	0%	75.17	$
VOD	-1.23%	15.5	$
JRI	-0.85%	11.83	$
BP	-0.02%	44.58	$

Moderna to Present at Upcoming Conferences in March 2025

BOULEVARD 25.02.2025

CAMBRIDGE, MA / ACCESS Newswire / February 25, 2025 / Moderna, Inc. (Nasdaq: MRNA), today announced its participation in the following upcoming investor conferences:

Text size:

TD Cowen 45^th Annual Health Care Conference, on Wednesday, March 5^th at 9:10am ET

Barclays 27^th Annual Global Healthcare Conference, on Tuesday, March 11^th at 1:30pm ET

A live webcast of each of these presentations will be available under "Events and Presentations" in the Investors section of the Moderna website.

Webcast: investors.modernatx.com.

A replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation.

About Moderna

Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.

Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.

Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
[email protected]

SOURCE: Moderna, Inc.

View the original press release on ACCESS Newswire

J.Oliveira--AMWN

American Marconi Wireless News - Moderna to Present at Upcoming Conferences in March 2025

Moderna to Present at Upcoming Conferences in March 2025

Featured

David Walliams Identified as Celebrity in Sexual Misconduct Allegations After Legal Bid

Regal Moviegoers Get the Chance to Purchase Collectible Tickets with the Hunger Games: Sunrise on the Reaping

Vanta Announces Appointment of Chief Financial Officer and Corporate Secretary

Dolphin Entertainment Reports Record Revenue in Third Quarter 2026